Pharmaceutical Technology

NOVEMBER 25, 2022

The treatment is indicated for usage in such patients following previous chemotherapy, comprising trastuzumab and a taxane. Nausea, fatigue, vomiting, reduced neutrophil count, alopecia and anaemia among others were observed to be the most prevalent adverse reactions.

Adverse Reactions 105

Adverse Reactions Chemotherapy Labelling 105

The Checkup by Singlecare

APRIL 14, 2024

Technically, treating animals is an off-label use for this antibacterial and antimicrobial drug, but metronidazole works for anaerobic bacteria infections, inflammatory bowel disease, giardia, acute diarrhea , and dental infections. Certain supplements, flea medications, and chemotherapy drugs may also cause adverse reactions.

Dosage 98

Dosage Adverse Reactions Chemotherapy Labelling 98

The Checkup by Singlecare

JUNE 20, 2023

If your immune system is compromised due to medication, chemotherapy, or radiation therapy, probiotics may increase the risk of developing a bacterial or fungal infection. Anyone with food allergies should thoroughly review the label, research the company, and consult their allergist or healthcare provider before taking probiotics.

Immunization 98

Immunization Adverse Reactions Chemotherapy Compounding 98

The Checkup by Singlecare

OCTOBER 16, 2023

What Are the Off-Label Uses for Cymbalta? Cymbalta may have several off-label uses in addition to its FDA-approved uses. Migraine Headaches Another off-label use of Cymbalta is for the management of migraine headaches. The medication may help strengthen the muscles that control urine flow and improve overall bladder function.

Dosage 52

Dosage Insurance Coverage Labelling Insurance 52

The Checkup by Singlecare

OCTOBER 27, 2023

By bringing up a potential interaction with amoxicillin-potassium clavulanate, you could avoid an adverse reaction or, at the very least, have peace of mind and a better understanding of why it is being prescribed for you. Taking an active role in your own care is essential for the best outcomes.

Adverse Reactions 52

Adverse Reactions Labelling Chemotherapy Communication 52

Pharmaceutical Technology

FEBRUARY 5, 2023

The FDA approval is based on the data obtained from a global, multicentre, open-label Phase III TROPiCS-02 study conducted in 543 HR+/HER2- metastatic breast cancer patients who have received prior endocrine therapy, CDK4/6 inhibitor and two to four lines of chemotherapy for metastatic disease. Trodelvy showed 3.2 Trodelvy showed 3.2

FDA 105

FDA Adverse Reactions Chemotherapy Labelling 105

Pharmaceutical Technology

MARCH 23, 2023

The approval from the FDA was based on the data obtained from the multiregional, open-label, single-arm POD1UM-201 trial, conducted in metastatic or recurrent locally-advanced MCC adults who did not receive systemic therapy previously for their advanced disease. Partial response was seen in 22 patients and complete response in 12 patients.

FDA 98

FDA Adverse Reactions Compounding Chemotherapy 98